In the original version of this article (1), the “Crizotinib” label in Fig. 4F is incorrect; the label should be “Selumetinib”. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.
H, et al
KRAS inhibitor resistance in MET-amplified KRASG12C non–small cell lung cancer induced by RAS- and non–RAS-mediated cell signaling mechanisms.
Clin Cancer Res
©2022 American Association for Cancer Research
American Association for Cancer Research